Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000892569-95-000119
Filing Date
1995-03-31
Accepted
1995-03-31 00:00:00
Documents
19
Period of Report
1994-12-31
SROs
NYSE

Document Format Files

Seq Description Document Type Size
1 ICN PHARMACEUTICALS INC. - FORM 10-K 10-K 370112
2 EXHIBIT 10.23 EX-10.23 8924
3 EXHIBIT 10.24 EX-10.24 6439
4 EXHIBIT 10.25 EX-10.25 5467
5 EXHIBIT 10.26 EX-10.26 6427
6 EXHIBIT 10.27 EX-10.27 6492
7 EXHIBIT 10.28 EX-10.28 7888
8 EXHIBIT 10.29 EX-10.29 5013
9 EXHIBIT 10.30 EX-10.30 6505
10 EXHIBIT 10.31 EX-10.31 3388
11 EXHIBIT 10.32 EX-10.32 6024
12 EXHIBIT 10.33 EX-10.33 3414
13 EXHIBIT 10.34 EX-10.34 5699
14 EXHIBIT 10.35 EX-10.35 5587
15 EXHIBIT 10.36 EX-10.36 5795
16 EXHIBIT 11 EX-11 3845
17 EXHIBIT 21 EX-21 4609
18 EXHIBIT 23 EX-23 1034
19 EXHIBIT 27 EX-27 2948
  Complete submission text file 0000892569-95-000119.txt   467363
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
ICN PHARMACEUTICALS INC (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-11397 | Film No.: 95525964
SIC: 2834 Pharmaceutical Preparations